查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
蛋白質體學生物標記分析市場:各用途，各技術，各產品，場所預測 - 附執行顧問指南(2024年～2028年)
市場調查報告書
商品編碼
1472604

蛋白質體學生物標記分析市場:各用途，各技術，各產品，場所預測 - 附執行顧問指南(2024年～2028年)

Proteomic Biomarker Analytics Markets. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 303 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球蛋白質體學生物標記分析市場相關調查，市場概要，以及各用途，各技術，各產品，場所趨勢，及加入此市場的主要企業的簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 蛋白質體學生物標記分析是什麼嗎
  • 蛋白質體學和醫藥品開發
  • 市場定義
  • 調查手法

第3章 蛋白質體學生物標記分析- 技術指南

  • 方法
    • 分離技術和電泳
    • 質譜分析
    • 層析法
    • 印跡
    • 蛋白質互補性化驗和相互作用篩檢
    • 蛋白質結構預測
    • 蛋白質資料庫

第4章 產業概要

  • 市場進入組織
    • 學術研究機關
    • 診斷測試開發商
    • 儀器供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關

第5章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素

第6章 蛋白質體學生物標記分析的最近進步

第7章 蛋白質體學生物標記分析的主要企業簡介

  • Abbott Laboratories
  • Abcam
  • Agilent
  • Amprion
  • ATUM
  • BasePair Biotechnologies
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • Biomatik
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bruker
  • C2N Diagnostics
  • Cepheid(Danaher)
  • Diadem Diagnostics
  • Eve Technologies
  • Fujirebio
  • Hybrigenics Services
  • MRM Proteomics Inc.
  • NanoDx
  • Nautilus Biotechnology
  • Nicoya
  • Nuclera
  • Olink
  • Qiagen
  • Quanterix
  • Roche Diagnostics
  • Second Genome
  • Siemens Healthineers
  • Sphingotec
  • Thermo Fisher Scientific
  • Unchained Labs

第8章 全球蛋白質體學生物標記分析市場

  • 各國:全球市場概要
  • 各用途:全球市場概要
  • 各技術:全球市場概要
  • 各產品:全球市場概要
  • 場所:全球市場概要

第9章 全球蛋白質體學生物標記分析市場:各用途

  • 藥物研發
  • 研究
  • 臨床診斷
  • 其他

第10章 全球蛋白質體學生物標記分析市場:各技術

  • 質譜分析
  • ELISA/珠
  • 混合多工
  • 其他

第11章 全球蛋白質體學生物標記分析市場:各產品

  • 設備
  • 套件和試劑
  • 服務

第12章 全球蛋白質體學生物標記分析市場:場所

  • 學術機構
  • 製藥公司/生物科技企業
  • 臨床
  • 其他

第13章 附錄

OVERVIEW:

Where genomics can't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is huge. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What is Proteomic Biomarker Analytics?
  • 2.2. Proteomics and Drug Development
  • 2.3. Market Definition
    • 2.3.1. Market Size
    • 2.3.2. Currency
    • 2.3.3. Years
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors

3. Proteomic Biomarker Analytics-Guide to Technologies

  • 3.1. Methods
    • 3.1.1. Separation techniques and electrophoresis
    • 3.1.2. Mass spectrometry
    • 3.1.3. Chromatography
    • 3.1.4. Blotting
    • 3.1.5. Protein complementation assays and interaction screens
    • 3.1.6. Protein structure prediction
    • 3.1.7. Protein databases

4. Industry Overview

  • 4.1. Players in a Dynamic Market
  • 4.2. Academic Research Lab
  • 4.3. Diagnostic Test Developer
  • 4.4. Instrumentation Supplier
  • 4.5. Chemical/Reagent Supplier
  • 4.6. Pathology Supplier
  • 4.7. Independent Clinical Laboratory
  • 4.8. Public National/regional Laboratory
  • 4.9. Hospital Laboratory
  • 4.10. Physicians Office Lab (POLS)
  • 4.11. Audit Body
  • 4.12. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Drug Development
    • 5.1.2. Companion Dx
    • 5.1.3. Fertile Research
    • 5.1.4. Technology Convergence
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve
    • 5.2.2. Capacity Constraints
    • 5.2.3. Market Lag

6. Proteomic Analytics Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Mass Spec Test to Detect Ovarian Cancer
  • 6.3. Proteomic Multiple Sclerosis Test Gaining Traction
  • 6.4. Emory U Protein Panel Could Diagnose Alzheimer's Disease
  • 6.5. Amprion's Parkinson's Disease Dx Shows Strong Performance
  • 6.6. Single-Cell Proteomics Bypasses Bottlenecks
  • 6.7. SomaLogic Seeks 'Strategic Alternatives' for Dx Business
  • 6.8. Alzheimer's Dx Study to Add Genomic, Proteomic Profiling
  • 6.9. NanoDx Prepares for POC Platform Commercialization
  • 6.10. DeepMind AI Predicts 3D Structure of Every Protein
  • 6.11. Quanterix Slashing Workforce by 25 Percent
  • 6.12. Study Shows Potential of NanoMosaic's Platform for Biomarker Development
  • 6.13. Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra
  • 6.14. PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications
  • 6.15. Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
  • 6.16. Proteomics Goes Public

7. Profiles of Key Proteomic Biomarker Analytic Companies

  • 7.1. Abbott Laboratories
  • 7.2. Abcam
  • 7.3. Agilent
  • 7.4. Amprion
  • 7.5. ATUM
  • 7.6. BasePair Biotechnologies
  • 7.7. Beckman Coulter Diagnostics (Danaher)
  • 7.8. Becton, Dickinson and Company
  • 7.9. Biomatik
  • 7.10. Bio-Rad Laboratories, Inc
  • 7.11. Bio-Techne
  • 7.12. Bruker
  • 7.13. C2N Diagnostics
  • 7.14. Cepheid (Danaher)
  • 7.15. Diadem Diagnostics
  • 7.16. Eve Technologies
  • 7.17. Fujirebio
  • 7.18. Hybrigenics Services
  • 7.19. MRM Proteomics Inc.
  • 7.20. NanoDx
  • 7.21. Nautilus Biotechnology
  • 7.22. Nicoya
  • 7.23. Nuclera
  • 7.24. Olink
  • 7.25. Qiagen
  • 7.26. Quanterix
  • 7.27. Roche Diagnostics
  • 7.28. Second Genome
  • 7.29. Siemens Healthineers
  • 7.30. Sphingotec
  • 7.31. Thermo Fisher Scientific
  • 7.32. Unchained Labs

8. Global Proteomic Analytics Markets

  • 8.1. PROTEIN ANALYTICS-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart-Global Market by Country
  • 8.2. Global Market by Application-Overview
    • 8.2.1. Table-Global Market by Application
    • 8.2.2. Chart-Global Market by Application-Segments Growth
    • 8.2.3. Chart-Global Market by Application-Base/Final Comparison
    • 8.2.4. Chart-Global Market by Application-Base Year
    • 8.2.5. Chart-Global Market by Application-Final Year
    • 8.2.6. Chart-Global Market by Application-Share by Year
  • 8.3. Global Market by Technology-Overview
    • 8.3.1. Table-Global Market by Technology
    • 8.3.2. Chart-Global Market by Technology-Segments Growth
    • 8.3.3. Chart-Global Market by Technology-Base/Final Comparison
    • 8.3.4. Chart-Global Market by Technology-Base Year
    • 8.3.5. Chart-Global Market by Technology-Final Year
    • 8.3.6. Chart-Global Market by Technology-Share by Year
  • 8.4. Global Market by Product-Overview
    • 8.4.1. Table-Global Market by Product
    • 8.4.2. Chart-Global Market by Product-Segments Growth
    • 8.4.3. Chart-Global Market by Product-Base/Final Comparison
    • 8.4.4. Chart-Global Market by Product-Base Year
    • 8.4.5. Chart-Global Market by Product-Final Year
    • 8.4.6. Chart-Global Market by Product-Share by Year
  • 8.5. Global Market by Place-Overview
    • 8.5.1. Table-Global Market by Place
    • 8.5.2. Chart-Global Market by Place-Segments Growth
    • 8.5.3. Chart-Global Market by Place-Base/Final Comparison
    • 8.5.4. Chart-Global Market by Place-Base Year
    • 8.5.5. Chart-Global Market by Place-Final Year
    • 8.5.6. Chart-Global Market by Place-Share by Year

9. Global PROTEIN ANALYTICS Markets-By Application

  • 9.1. PROTEIN ANALYTICS Drug Discovery
    • 9.1.1. Table PROTEIN ANALYTICS Drug Discovery-by Country
    • 9.1.2. Chart-PROTEIN ANALYTICS Drug Discovery Growth
  • 9.2. PROTEIN ANALYTICS Research Application
    • 9.2.1. Table PROTEIN ANALYTICS Research Application-by Country
    • 9.2.2. Chart-PROTEIN ANALYTICS Research Application Growth
  • 9.3. PROTEIN ANALYTICS Clinical Dx
    • 9.3.1. Table PROTEIN ANALYTICS Clinical Dx-by Country
    • 9.3.2. Chart-PROTEIN ANALYTICS Clinical Dx Growth
  • 9.4. PROTEIN ANALYTICS Other Applications
    • 9.4.1. Table PROTEIN ANALYTICS Other Applications-by Country
    • 9.4.2. Chart-PROTEIN ANALYTICS Other Applications Growth

10. Global PROTEIN ANALYTICS Markets-By Technology

  • 10.1. PROTEIN ANALYTICS Mass Spectrometry
    • 10.1.1. Table PROTEIN ANALYTICS Mass Spectrometry-by Country
    • 10.1.2. Chart-PROTEIN ANALYTICS Mass Spectrometry Growth
  • 10.2. PROTEIN ANALYTICS ELISA/Beads
    • 10.2.1. Table PROTEIN ANALYTICS ELISA/Beads-by Country
    • 10.2.2. Chart-PROTEIN ANALYTICS ELISA/Beads Growth
  • 10.3. PROTEIN ANALYTICS Hybrid Multiplex
    • 10.3.1. Table PROTEIN ANALYTICS Hybrid Multiplex-by Country
    • 10.3.2. Chart-PROTEIN ANALYTICS Hybrid Multiplex Growth
  • 10.4. PROTEIN ANALYTICS Other Technology
    • 10.4.1. Table PROTEIN ANALYTICS Other Technology-by Country
    • 10.4.2. Chart-PROTEIN ANALYTICS Other Technology Growth

11. Global PROTEIN ANALYTICS Markets-By Product

  • 11.1. PROTEIN ANALYTICS Instruments
    • 11.1.1. Table PROTEIN ANALYTICS Instruments-by Country
    • 11.1.2. Chart-PROTEIN ANALYTICS Instruments Growth
  • 11.2. PROTEIN ANALYTICS Kits & Reagents
    • 11.2.1. Table PROTEIN ANALYTICS Kits & Reagents-by Country
    • 11.2.2. Chart-PROTEIN ANALYTICS Kits & Reagents Growth
  • 11.3. PROTEIN ANALYTICS Services
    • 11.3.1. Table PROTEIN ANALYTICS Services-by Country
    • 11.3.2. Chart-PROTEIN ANALYTICS Services Growth

12. Global PROTEIN ANALYTICS Markets-By Place

  • 12.1. PROTEIN ANALYTICS Academic
    • 12.1.1. Table PROTEIN ANALYTICS Academic-by Country
    • 12.1.2. Chart-PROTEIN ANALYTICS Academic Growth
  • 12.2. PROTEIN ANALYTICS Pharma/Biotech
    • 12.2.1. Table PROTEIN ANALYTICS Pharma/Biotech-by Country
    • 12.2.2. Chart-PROTEIN ANALYTICS Pharma/Biotech Growth
  • 12.3. PROTEIN ANALYTICS Clinical
    • 12.3.1. Table PROTEIN ANALYTICS Clinical-by Country
    • 12.3.2. Chart-PROTEIN ANALYTICS Clinical Growth
  • 12.4. PROTEIN ANALYTICS Other Place
    • 12.4.1. Table PROTEIN ANALYTICS Other Place-by Country
    • 12.4.2. Chart-PROTEIN ANALYTICS Other Place Growth

13. Appendices

  • 13.1. Clinical Laboratory Fee Schedule
  • 13.2. The Most Used IVD Assays
  • 13.3. The Highest Grossing Assays
  • 13.4. The Changing IVD Menu
    • 13.4.1. Approved IVD Test Menu History
  • 13.5. The Changing Picture on Reimbursement

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Three Factors Limiting Growth
  • Table 4: Market Size by Country
  • Table 5: Global Market by Application
  • Table 6: Global Market by Technology
  • Table 7: Global Market by Product
  • Table 8: Global Market by Place
  • Table 9: PROTEIN ANALYTICS Drug Discovery by Country
  • Table 10: PROTEIN ANALYTICS Research Application by Country
  • Table 11: PROTEIN ANALYTICS Clinical Dx by Country
  • Table 12: PROTEIN ANALYTICS Other Applications by Country
  • Table 13: PROTEIN ANALYTICS Mass Spectrometry by Country
  • Table 14: PROTEIN ANALYTICS Hybrid Multiplex by Country
  • Table 15: PROTEIN ANALYTICS Other Technology by Country
  • Table 16: PROTEIN ANALYTICS Instruments by Country
  • Table 17: PROTEIN ANALYTICS Kits & Reagents by Country
  • Table 18: PROTEIN ANALYTICS Services by Country
  • Table 19: PROTEIN ANALYTICS Academic by Country
  • Table 20: PROTEIN ANALYTICS Pharma/Biotech by Country
  • Table 21: PROTEIN ANALYTICS Clinical by Country
  • Table 22: PROTEIN ANALYTICS Other Place by Country
  • Table 23: Clinical Lab Fee Schedule
  • Table 24: The Most Common Assays
  • Table 25: Largest Revenue Assays

Table of Figures

  • Figure 1: The Road to Diagnostics
  • Figure 2: Base year Global Market Share Chart
  • Figure 3: PROTEIN ANALYTICS Market by Application-Segments Growth
  • Figure 4: PROTEIN ANALYTICS Market by Application-Base vs. final
  • Figure 5: PROTEIN ANALYTICS Market Base year
  • Figure 6: PROTEIN ANALYTICS Market Final Year
  • Figure 7: PROTEIN ANALYTICS Application Share by Year
  • Figure 8: PROTEIN ANALYTICS Market by Technology-Segments Growth
  • Figure 9: PROTEIN ANALYTICS Market by Technology-Base vs. final
  • Figure 10: PROTEIN ANALYTICS Market by Technology Base year
  • Figure 11: PROTEIN ANALYTICS Market by Technology Final Year
  • Figure 12: PROTEIN ANALYTICS Technology Share by Year
  • Figure 13: PROTEIN ANALYTICS Market by Product-Segments Growth
  • Figure 14: PROTEIN ANALYTICS Market by Product-Base vs. final
  • Figure 15: PROTEIN ANALYTICS Market by Product Base year
  • Figure 16: PROTEIN ANALYTICS Market by Product Final Year
  • Figure 17: Product Share by Year
  • Figure 18: PROTEIN ANALYTICS Market by Place-Segments Growth
  • Figure 19: PROTEIN ANALYTICS Market by Place-Base vs. final
  • Figure 20: PROTEIN ANALYTICS Market by Place Base year
  • Figure 21: PROTEIN ANALYTICS Market by Place Final Year
  • Figure 22: Place Share by Year
  • Figure 23: PROTEIN ANALYTICS Drug Discovery Growth
  • Figure 24: PROTEIN ANALYTICS Research Application Growth
  • Figure 25: PROTEIN ANALYTICS Clinical Dx Growth
  • Figure 26: PROTEIN ANALYTICS Other Applications Growth
  • Figure 27: PROTEIN ANALYTICS Mass Spectrometry Growth
  • Figure 28: PROTEIN ANALYTICS ELISA/Beads Growth
  • Figure 29: PROTEIN ANALYTICS Hybrid Multiplex Growth
  • Figure 30: PROTEIN ANALYTICS Other Technology Growth
  • Figure 31: PROTEIN ANALYTICS Instruments Growth
  • Figure 32: PROTEIN ANALYTICS Kits & Reagents Growth
  • Figure 33: PROTEIN ANALYTICS Services Growth
  • Figure 34: PROTEIN ANALYTICS Academic Growth
  • Figure 35: PROTEIN ANALYTICS Pharma/Biotech Growth
  • Figure 36: PROTEIN ANALYTICS Clinical Growth
  • Figure 37: PROTEIN ANALYTICS Other Place Growth
  • Figure 38: The Growing Menu of Approved Assays
  • Figure 39: The Changing Reimbursement Picture